ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
La Jolla Receives European Commission Approval for Giapreza
September 03, 2019La Jolla announced that the European Commission (EC) has approved GIAPREZA™ (angiotensin II) for the treatment of refractory hypotension in adults with septic or other distributive shock... -
lonza Shimadzu FDA Approves Drug to Treat Dangerously Low Blood Pressure
December 27, 2017The U.S. Food and Drug Administration (FDA) approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.
Pharma Sources Insight January 2025
